INTRODUCTION
At present, liver transplantation is considered as the best curative option for end-stage liver diseases. However, the limitations of liver transplantation, such as the shortage of organ donors, have made the process long and difficult for peri-transplantation courses. Therefore, the adverse effects caused by life-long immunosuppressive regimens have prompted the efforts to find the alternative.
Hepatocyte transplantation was first considered, how-ever, it also faced several difficulties, which include the unsolved problem of donor shortage, troublesome processes of cultivation, and requirement of immunosuppressive regimens. Under these circumstances, many investigators have researched stem cell transplantation with the hope of overcoming these limitations.
Of all the possible stem cell lines, we paid attention to the adult stem cells, especially mesenchymal stem cells (MSCs). MSCs were proven to have the ability to proliferate extensively, and to differentiate into multiple cell types [1, 2] . In addition, MSCs are known to circumvent immunocompatibility problems because they have low expressions of human leukocyte antigen (HLA) I and no HLA II, as well as a low risk of allogenic rejection and graft-versus-host disease [3, 4] . Various tissues, such as the bone marrow, amniotic fluid, placenta, umbilical cord blood, scalp tissue, placenta, and adipose tissue, were known to contain MSCs [5] [6] [7] [8] [9] .
In our study, we intended to evaluate the therapeutic potential of the adipose tissue. Zuk et al. [9, 10] first demonstrated the adipse tussue-derived stem cells' (ADSCs) potential for a multi-lineage differentiation, and Seo et al. [11] reported the first successful hepatocytic differentiation from ADSCs. Thereafter, numerous trials have applied ADSCs into hepatic failure animal models and demonstrated the therapeutic potentials of ADSCs transplantation [12] [13] [14] [15] [16] [17] . However, the exact mechanism by which ADSCs improve the liver dysfunction in a hepatic injured animal model remains to be clarified. Most researchers have focused on the possibility that the transplanted ADSCs become engulfed in the liver, where they act as hepatocyte through transdifferentiation or fusion [11, 12, [14] [15] [16] [17] . Therefore, they have attempted to establish differentiated ADSCs in vitro prior to a transplantation.
However, it also has been proposed that MSCs act as trophic mediators, by which they secrete bioactive factors to ameliorate the liver damage [13, 18] . To prove this ADSCs' hormonal effect, the therapeutic effect of undifferentiated ADSCs should first be demonstrated. Therefore, the purpose of this study was to evaluate the therapeutic ability of undifferentiated ADSCs, and find a clue on how ADSCs alleviate liver damage by comparing the transplantation routes. 
METHODS

Stem cell isolation and culture
Identification of cell characteristics
ADSCs transplantation into mice with CCl4-induced injury
4, 6-diamidino-2-phenylindole (DAPI) labeling
For the identification of ADSCs after the transplantation, ADSCs nuclei were stained using DAPI (SigmaAldrich). DAPI was added to the media to a final concentration of 50 mg/mL. The cells were incubated at 37°C under 5% CO2 for 30 minutes, then washed six times in PBS. posed using a wet cotton swab. A purse-string suture using a prolene 6-0 (Ethicon Inc., Somerville, NJ, USA) was made around a presumed infusion site. Then, ADSCs were infused slowly for 1 minute, and thereafter, the purse-string suturing was completed. In the LP group, the same laparotomy as the PV group was made. After putting a superior lobe aside, the infusion was solely performed into a medial lobe after the placement of purse-string suture. After the infusion, purse-string suturing was completed. Lastly, in TV the group, transplantation was made via tail vein without anesthesia.
Accessment of transplantation outcome
Serum biochemical markers
Blood samples were obtained from each mouse at 1 day and 3 days after the transplantation, centrifuged for 20 minutes at 400 g, and its serum was collected. The concentration of biochemical parameters such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), and ammonia were analyzed by using a IDEXX VetTest Chemistry Analyzer (IDEXX Laboratories Inc., Westbrook, ME, USA).
Hematoxylin-esosin (HE) stain & immunohistochemistry
HE staining was performed to find the changes in histological architecture, and Ki67 stain was followed to evaluate the degree of proliferation. Liver specimens were pre- 
Statistical analysis
All data were analyzed with SPSS ver. 11.0 (SPSS Inc., Chicago, IL, USA), and are presented as mean ± SD or median (range). A P-value ＜ 0.05 was considered significant.
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RESULTS
Cell characterization
Morphology
ADSCs were cultivated in DMEM/F-12 containing 10% FBS, and were replated when they reached an 80%
confluence. ADSCs initially appeared as a spindle shape, reminding of fibroblasts ( Fig. 2A) . After the 3-day endodermal Activin A and FGF4 induction period, this fibroblast-like morphology was progressively changed into an oval shape (Fig. 2B ).
Flow cytometry
To specify the antigenic properties of ADSCs, cell surface protein expression was determined by flow cytometry. Flow cytometric analysis confirmed the expressions of the MSC markers (CD29, CD105, and CD166) in all three donors, however not the hematopoietic stem cell marker (CD34) (Fig. 3) .
RT-PCR
Gene expression of undifferentiated ADSCs was com- were not (Fig. 4) .
ADSC transplantation into mice with liver failure
DAPI immunofluoresence
ADSCs labeled by DAPI had round or oval light blue spots when viewed under the fluorescence microscope, and most ADSCs appeared to be labeled. We transplanted (Fig. 5A ). In the PV group, DAPI-positive cells were observed in clusters, scattered throughout every lobe of the liver (Fig. 5B) . In the LP group, DAPI-positive cells were mainly restricted in the injected lobe, forming a cluster nature (Fig. 5C ). To estimate the amount of en- thesurgery.or.kr 
Histological staining
HE staining was performed to find the changes in histological architecture, and Ki67 stain was followed to evaluate the degree of proliferation. Normal mouse liver showed well-organized hepatic cords in a HE stain, and unstained nuclei in a Ki67 stain suggested a low proliferation status (control group). Twenty-four hours after the CCl4 injection, centrilobular necrosis was observed in a HE stain (HF group). Additionally, no nucleus was stained with Ki67 stain in the HF group. Histological stains were obtained 24 hours after the transplantation. In the TV group, reduction of the necrosis area was observed when it was compared to the SL group, and several nuclei stained with Ki67 emerged. Such an improvement -the reduction of the necrosis area, and the emergence of Ki67 stained nuclei-was also observed in the TV and LP group.
The degree of improvement was most prominent in the TV group, followed by the PV group, the LP group, respectively (Fig. 6 ).
Biochemical parameters
Twenty-four hours after the CCl4 i.p. injection, biochemical parameters such as AST, ALT, and ammonia were significantly increased in the HF group, when it was compared to the control group. Next, we evaluated the therapeutic potential according to the transplantation routes (Fig. 7) . One day after the ADSCs transplantation, sue is known to be, maximally, about 40 times more than the yield from the bone marrow [22, 23] . Lastly, in-vitro expansion of ADSC can be performed conveniently.
Over the past two decades after the discovery of stem cells in the adipose tissue [9] , the therapeutic potential of ADSCs to the liver disease have been explored. However, numerous reports focused on the hepatic differentiation of ADSCs, because they thought that the ADSCs' therapeutic potential originated from the functionally differentiated stem cells. However, it was also known that stem cells can act as paracrine or endocrine cells to affect adjacent cells by secreting bioactive factors. Rehman et al. [18] reported that adipose stromal cells, which had been obtained from human subcutaneous adipose tissue, secreted considerable amount of vascular endothelial growth factor, hepatocyte growth factor, and transforming growth factor-β. Moreover, Banas et al. [13] later observed that ADSCs secreted a higher volume of interleukin 1 receptor α (IL-1Rα), IL-6, IL-8, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage (GM-CSF), monocyte chemotactic protein 1, and nerve growth factor than MSCs originated from either the bone marrow or human dermal fibroblasts did. In our study, we demonstrated a definite decline in the liver enzyme levels after an undifferentiated ADSC transplantation. The changes were observed one day after the transplantation, and became prominent 3 days after the transplantation. Because a 24-hour period is not sufficient for ADSCs to differentiate into full-grown hepatocytes, it is natural to think that the systemic changes induced by ADSCs might have contributed to it. Our observation was also in line with other reports [13, 16] . We think that our result provides a substantial meaning when it is applied to a clinical setting. Acute liver failure is a catastrophe which can lead to death. Moreover, there is a very limited time window to treat and save the patients.
However, inducing a hepatic differentiation needs fixed time, ranging from 2 weeks to several months [11, 12, [14] [15] [16] [17] .
Therefore, it is our opinion that if the undifferentiated ADSCs' effectiveness can be proved in a clinical setting, a number of patients can receive a potentially life-saving treatment within that small window of time.
In this experiment, the therapeutic potentials according to the transplantation route were compared. Until now, in most studies, ADSC transplantations have been attempted by a peripheral vein [11] [12] [13] [14] 17] , and uncommonly, via portal vein [15] and direct liver parenchyma [16] . We think that a study of the transplantation route can give essential information about how ADSCs influence the injured liver. After a liver injury, a systemic change occurs [24] [25] [26] [27] [28] [29] ; the SDF-1, G-CSF, and other mediator expressions increase in the peripheral blood, whereas the SDF-1 and 
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